Hypertrophic Cardiomyopathy Clinical Trial
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
Summary
This is a non-invasive/observational study in healthy and mild HF subjects utilizing clinical and ambulatory measurements to improve detection, monitoring, and management of HF risks.
Eligibility Criteria
Key Inclusion Criteria:
Cohort 2: Confirmed medical history of LVH based on American College of Cardiology (ACC)/American Heart Association (AHA) guidelines and NYHA Class I at screening
Cohort 3: Confirmed medical history of HF consistent with current ACC/AHA guidelines and NYHA Class I at screening
Cohort 4: Confirmed medical history of HCM consistent with ACC/AHA guidelines and NYHA Class I or II at screening
Key Exclusion Criteria:
Active neurological disorder, such as uncontrolled seizure disorder.
Current diagnosis of cancer or other known acute chronic infection, such as hepatitis B or hepatitis C, by medical history or an active infection requiring interventional therapy at screening.
Shortness of breath, fatigue, heart palpitations, pain, or other limitations of physical activity
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Jacksonville Florida, 32216, United States
How clear is this clinincal trial information?